Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report-Reference-Cited by-同舟云学术

Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report

Published:2023-03-29 Issue:5 Volume:25 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Deng Jiaxi¹,Lin Xinqing¹,Deng Haiyi¹,Yang Yilin¹,Guan Wenhui¹,Xie Xiaohong¹,Zhou Chengzhi¹

Affiliation:

1. Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference17 articles.

1. The 2021 WHO classification of lung tumors: Impact of advances since 2015;Nicholson;J Thorac Oncol,2022

2. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma;Min;Gastric Cancer,2016

3. Primary pulmonary lymphoepithelioma-like carcinoma response favorably to nivolumab: A case report;Qiu;Onco Targets Ther,2019

4. Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review;Hao;Front Oncol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr virus monitoring for preemptive re‐hematopoietic cell transplantation in CD3δ‐deficient siblings;Pediatric Blood & Cancer;2024-06-04

2. Bevacizumab/nivolumab/toripalimab;Reactions Weekly;2023-06-10